The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
Authors:
Open Access
- 17 February 2009
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 100 (5) , 676-679
Abstract
RUNX3 is believed to have tumour suppressor properties in several cancer types. Inactivation of RUNX3 has been shown to occur by methylation-induced transcriptional silencing and by mislocalization of the protein to the cytoplasm. The aim of this study was to examine the clinical significance of RUNX3 expression in a large series of colorectal cancers using immunohistochemistry and tissue arrays. With advancing tumour stage, expression of RUNX3 in the nucleus decreased, whereas expression restricted to the cytoplasmic compartment increased. Nuclear RUNX3 expression was associated with significantly better patient survival compared to tumours in which the expression of RUNX3 was restricted to the cytoplasm (P=0.025). These results support a role for RUNX3 as a tumour suppressor in colorectal cancer.Keywords
This publication has 21 references indexed in Scilit:
- Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 MethylationJournal of Biological Chemistry, 2008
- RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progressionBreast Cancer Research and Treatment, 2008
- Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based SampleThe Journal of Molecular Diagnostics, 2007
- TGF-β signaling alterations and susceptibility to colorectal cancerHuman Molecular Genetics, 2007
- Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosisOncogene, 2007
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Loss of RUNX3 Expression Significantly Affects the Clinical Outcome of Gastric Cancer Patients and Its Restoration Causes Drastic Suppression of Tumor Growth and MetastasisCancer Research, 2005
- Expression of RUNX3 protein in human lung adenocarcinoma: Implications for tumor progression and prognosisCancer Science, 2005
- Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancersInternational Journal of Cancer, 2004
- RUNX transcription factors as key targets of TGF-β superfamily signalingCurrent Opinion in Genetics & Development, 2003